Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion type Assertion NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_head.
- NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion wasGeneratedBy ECO_0000203 NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_provenance.
- NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion wasDerivedFrom befree-20150227 NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_provenance.
- NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion SIO_000772 8690051 NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_provenance.
- NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion evidence source_evidence_literature NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_provenance.
- NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661197.RALnuQ-RovO-9lJWzqCQy2ennmOjjybsyr4QjOu149IQk130_provenance.